D
GoodRx Holdings, Inc.
GDRX
$4.48
$0.0050.11%
D
Sell
3/6/2025Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D+ from D on 3/6/2025 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 88.84% from $20.41M to $38.54M, earnings per share increased from $0.01 to $0.0177, and net income increased 69.99% from $3.97M to $6.74M.
GoodRx Holdings, Inc. (GDRX) was upgraded to D+ from D on 3/6/2025 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 88.84% from $20.41M to $38.54M, earnings per share increased from $0.01 to $0.0177, and net income increased 69.99% from $3.97M to $6.74M.
D
Sell
8/15/2024Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D from E+ on 8/15/2024 due to a substantial increase in the efficiency index, total return index and volatility index. Net income increased 763.43% from -$1.01M to $6.69M, and total capital increased 2.65% from $1.34B to $1.38B.
GoodRx Holdings, Inc. (GDRX) was upgraded to D from E+ on 8/15/2024 due to a substantial increase in the efficiency index, total return index and volatility index. Net income increased 763.43% from -$1.01M to $6.69M, and total capital increased 2.65% from $1.34B to $1.38B.
E
Sell
3/4/2024Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D on 3/4/2024 due to a substantial decline in the efficiency index, solvency index and growth index. Operating cash flow declined 73.67% from $60.27M to $15.87M, debt to equity increased from 0.75 to 0.87, and the quick ratio declined from 7.98 to 6.92.
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D on 3/4/2024 due to a substantial decline in the efficiency index, solvency index and growth index. Operating cash flow declined 73.67% from $60.27M to $15.87M, debt to equity increased from 0.75 to 0.87, and the quick ratio declined from 7.98 to 6.92.
D
Sell
9/26/2023Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to D from D+ on 9/26/2023 due to a decline in the total return index and volatility index.
GoodRx Holdings, Inc. (GDRX) was downgraded to D from D+ on 9/26/2023 due to a decline in the total return index and volatility index.
D
Sell
9/11/2023Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D+ from D on 9/11/2023 due to a noticeable increase in the total return index, valuation index and volatility index.
GoodRx Holdings, Inc. (GDRX) was upgraded to D+ from D on 9/11/2023 due to a noticeable increase in the total return index, valuation index and volatility index.
D
Sell
8/11/2023Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D from E+ on 8/11/2023 due to a substantial increase in the efficiency index, volatility index and total return index. Net income increased 1,886.81% from -$3.29M to $58.79M, and total capital increased 4.3% from $1.54B to $1.61B.
GoodRx Holdings, Inc. (GDRX) was upgraded to D from E+ on 8/11/2023 due to a substantial increase in the efficiency index, volatility index and total return index. Net income increased 1,886.81% from -$3.29M to $58.79M, and total capital increased 4.3% from $1.54B to $1.61B.
E
Sell
3/14/2023Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D on 3/14/2023 due to a decline in the solvency index.
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D on 3/14/2023 due to a decline in the solvency index.
D
Sell
3/3/2023Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D from D- on 3/3/2023 due to a significant increase in the growth index and solvency index. EBIT increased 2,136.19% from $887 to $19.84M, earnings per share increased from -$0.1011 to -$0.0095, and the quick ratio increased from 10.03 to 11.52.
GoodRx Holdings, Inc. (GDRX) was upgraded to D from D- on 3/3/2023 due to a significant increase in the growth index and solvency index. EBIT increased 2,136.19% from $887 to $19.84M, earnings per share increased from -$0.1011 to -$0.0095, and the quick ratio increased from 10.03 to 11.52.
D
Sell
2/23/2023Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and valuation index.
GoodRx Holdings, Inc. (GDRX) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and valuation index.
E
Sell
2/8/2023Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 10.93 to 10.03, and debt to equity increased from 0.82 to 0.84.
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 10.93 to 10.03, and debt to equity increased from 0.82 to 0.84.
D
Sell
8/10/2022Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to D- from D on 8/10/2022 due to a significant decline in the growth index, solvency index and volatility index. EBIT declined 120.48% from $19.76M to -$4.05M, earnings per share declined from $0.0296 to -$0.0034, and the quick ratio declined from 16.42 to 10.93.
GoodRx Holdings, Inc. (GDRX) was downgraded to D- from D on 8/10/2022 due to a significant decline in the growth index, solvency index and volatility index. EBIT declined 120.48% from $19.76M to -$4.05M, earnings per share declined from $0.0296 to -$0.0034, and the quick ratio declined from 16.42 to 10.93.
D
Sell
5/16/2022Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D from E+ on 05/16/2022.
GoodRx Holdings, Inc. (GDRX) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/11/2022Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D from D- on 5/11/2022 due to a significant increase in the growth index and valuation index. Earnings per share increased from -$0.0964 to $0.0296, and EBIT increased 68.09% from $11.76M to $19.76M.
GoodRx Holdings, Inc. (GDRX) was upgraded to D from D- on 5/11/2022 due to a significant increase in the growth index and valuation index. Earnings per share increased from -$0.0964 to $0.0296, and EBIT increased 68.09% from $11.76M to $19.76M.
D
Sell
5/5/2022Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
GoodRx Holdings, Inc. (GDRX) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index, volatility index and valuation index.
GoodRx Holdings, Inc. (GDRX) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index, volatility index and valuation index.
D
Sell
3/15/2022Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to D- from D on 3/15/2022 due to a significant decline in the efficiency index, solvency index and volatility index. Net income declined 120.9% from -$18.07M to -$39.91M, the quick ratio declined from 14.29 to 13.16, and debt to equity increased from 0.79 to 0.8.
GoodRx Holdings, Inc. (GDRX) was downgraded to D- from D on 3/15/2022 due to a significant decline in the efficiency index, solvency index and volatility index. Net income declined 120.9% from -$18.07M to -$39.91M, the quick ratio declined from 14.29 to 13.16, and debt to equity increased from 0.79 to 0.8.
D
Sell
8/13/2021Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D from D- on 8/13/2021 due to a noticeable increase in the efficiency index, valuation index and solvency index. Net income increased 1,762.17% from $1.67M to $31.06M, debt to equity declined from 0.9 to 0.81, and total capital increased 5.07% from $1.45B to $1.53B.
GoodRx Holdings, Inc. (GDRX) was upgraded to D from D- on 8/13/2021 due to a noticeable increase in the efficiency index, valuation index and solvency index. Net income increased 1,762.17% from $1.67M to $31.06M, debt to equity declined from 0.9 to 0.81, and total capital increased 5.07% from $1.45B to $1.53B.
D
Sell
7/9/2021Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to D- from D on 7/9/2021 due to a decline in the volatility index.
GoodRx Holdings, Inc. (GDRX) was downgraded to D- from D on 7/9/2021 due to a decline in the volatility index.
D
Sell
6/16/2021Upgraded
GoodRx Holdings, Inc. (GDRX) was upgraded to D from D- on 6/16/2021 due to an increase in the volatility index.
GoodRx Holdings, Inc. (GDRX) was upgraded to D from D- on 6/16/2021 due to an increase in the volatility index.
D
Sell
6/1/2021Downgrade
GoodRx Holdings, Inc. (GDRX) was downgraded to D- from D on 6/1/2021 due to a decline in the efficiency index and volatility index.
GoodRx Holdings, Inc. (GDRX) was downgraded to D- from D on 6/1/2021 due to a decline in the efficiency index and volatility index.
D
Sell
12/16/2020None
GoodRx Holdings, Inc. (GDRX) was downgraded to D from U on 12/16/2020.
GoodRx Holdings, Inc. (GDRX) was downgraded to D from U on 12/16/2020.
NASDAQ
03/14/2025 11:41AM Eastern
Quotes delayed
